Description

861,000 equity shares of Shelter Pharma Limited listed on BSE effective January 21, 2026, issued on preferential basis pursuant to conversion of warrants.

Summary

BSE has listed 861,000 new equity shares of Shelter Pharma Limited (Scrip Code: 543963) effective January 21, 2026. These shares were issued to Non-Promoters on a preferential basis pursuant to conversion of warrants at an issue price of Rs. 42.25 per share (face value Rs. 10.00 with premium of Rs. 32.25). The allotment date was October 16, 2025, and the shares rank pari-passu with existing equity shares.

Key Points

  • 861,000 equity shares of Rs. 10/- each listed for trading
  • Issued on preferential basis to Non-Promoters through warrant conversion
  • Issue price: Rs. 42.25 per share (Rs. 10 face value + Rs. 32.25 premium)
  • Distribution numbers: 14001793 to 14862792
  • ISIN: INE013V01011
  • Shares rank pari-passu with existing equity shares
  • All shares subject to lock-in restrictions until August 2026

Regulatory Changes

No regulatory changes introduced by this circular.

Compliance Requirements

Trading members must note the listing of these new securities and ensure compliance with lock-in restrictions during transactions:

  • 336,000 shares (Dist. Nos. 14001793-14337792): Locked-in until August 14, 2026
  • 372,000 shares (Dist. Nos. 14337793-14709792): Locked-in until August 15, 2026
  • 153,000 shares (Dist. Nos. 14709793-14862792): Locked-in until August 14, 2026

Important Dates

  • Allotment Date: October 16, 2025
  • Trading Commencement: January 21, 2026
  • Lock-in Expiry (336,000 shares): August 14, 2026
  • Lock-in Expiry (372,000 shares): August 15, 2026
  • Lock-in Expiry (153,000 shares): August 14, 2026

Impact Assessment

Limited market impact expected as this is a routine listing event. The preferential allotment of 861,000 shares represents capital raising through warrant conversion. All shares are subject to lock-in periods extending until mid-August 2026, which will prevent immediate trading and limit liquidity impact. The shares rank equally with existing equity shares, maintaining uniform shareholder rights.

Impact Justification

Routine listing of preferential allotment shares with limited market impact due to small size (861,000 shares) and lock-in restrictions